The Patent Finder

ImmunoGen, Inc. (One-Half Interest)

Also on record
Records under this name other than patents ImmunoGen, Inc. (One-Half Interest) holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 4 of 4 · Back to ImmunoGen, Inc. (One-Half Interest)

PatentTitleStatus Expires Confidence
US 9,289,509Uses of Immunoconjugates Targeting CD138
Formerly held
Lapsed on the fee record
Ended Mar 22, 2024 · High confidence
Lapsed on the fee recordEnded Mar 22, 2024High confidence
US 9,011,864Method of Decreasing Cytotoxic Side-Effects and Improving Efficacy of Immunoconjugates
Formerly held
Lapsed on the fee record
Ended Apr 21, 2023 · High confidence
Lapsed on the fee recordEnded Apr 21, 2023High confidence
US 9,446,146Methods and Agents for Improving Targeting of CD138 Expressing Tumor Cells
Formerly held
Lapsed on the fee record
Ended Sep 20, 2020 · High confidence
Lapsed on the fee recordEnded Sep 20, 2020High confidence
US 9,387,261Immunoconjugates Targeting CD138 and Uses Thereof
Formerly held
Lapsed on the fee record
Ended Jul 12, 2020 · High confidence
Lapsed on the fee recordEnded Jul 12, 2020High confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited